Bahl & Gaynor Inc. reduced its stake in shares of Amgen Inc. ( NASDAQ:AMGN – Get Rating ) by 5.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 420,487 shares of the medical research company's stock after selling 25,751 shares during the period. Bahl & Gaynor Inc.'s holdings in Amgen were worth $110,437,000 as of its most recent SEC filing. A number of other hedge funds also recently made changes to their positions in the stock. Edmp Inc. lifted its stake in Amgen by 25,517.

https://www.dailypolitical.com/2023/05/18/bahl-gaynor-inc-sells-25751-shares-of-amgen-inc-nasdaqamgn.html

#dailypolitical